NCT02797964 2023-06-18A Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerSierra Oncology LLC - a GSK companyPhase 1/2 Completed107 enrolled 20 charts
NCT02873975 2022-10-21A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair DeficiencyDana-Farber Cancer InstitutePhase 2 Completed27 enrolled 13 charts
NCT00053989 2020-02-10NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersRoswell Park Cancer InstitutePhase 2 Completed41 enrolled 13 charts
NCT00856388 2019-11-13Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersRoswell Park Cancer InstitutePhase NA Completed62 enrolled 14 charts